ESG Trends in the Pharmaceutical & Biotechnology Industry

Presented by

V.E, Vigeo Eiris

About this talk

Understanding and leveraging ESG performance has never been more vital with its the rapid rise amongst investors and continued growth in the sustainable finance market. This webinar highlights the main concerns seen from an ESG solutions agency standpoint and emerging trends within the Pharmaceutical & Biotechnology sector. Join us to find out more about: • Material matters for Pharmaceutical & Biotechnology companies; • Trends on key aspects for the sector; • and Stakeholders’ perception of controversial activities. Featuring: • Zineb Raji - V.E's Research Manager of the Food and Health cluster • Jordi Lesaffer - V.E's Product Manager - Controversy Risk Assessment • Moderated by Nicolas Moriceau-Gomez - V.E's Head of Sustainability Rating Services To learn more about how we can help you on your sustainability journey, please contact or visit our Sustainability Rating Services page at To view our Pharmaceutical & Biotechnology Sector Report, visit: **THIS EVENT IS CLOSED TO PRESS AND MEDIA** For press and media inquiries please contact

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (6)
Subscribers (1281)
V.E is a global leader in ESG assessments, data, research, benchmarks and analytics. Leveraging our extensive proprietary database, we equip market players with the ESG insight they need to manage risks and better understand and address their social and environmental impact. Since 2019, Vigeo Eiris has been an Affiliate of Moody’s Corporation. Vigeo Eiris has an industry unique ISO 9001: 2015 quality certification for its processes relating to methodology, assessments, sale and delivery of its data to all types of investors and issuers. Vigeo Eiris is a Climate Bonds Initiative Verified Provider of Second Party Opinions. With a team of nearly 300 experts of 30 different nationalities, Vigeo Eiris is present in Paris headquartered), London, Brussels, Casablanca, Hong Kong, Milan, New York, Rabat and Santiago. The Vigeo Eiris Global Network, comprising of 4 exclusive research partners, is present in Brazil, Germany, Israel and Japan.